# Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation, Launch Set for June

- URL: https://theranews.net/blog/2026-05-03-axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-46a257/
- Published: 2026-05-03
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: thelincolnianonline
- Original report: https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html
- Topics: alzheimers-dementia
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> Axsome Therapeutics (NASDAQ:AXSM) announced that the U.S. Food and Drug Administration has approved Auvelity for the treatment of agitation associated with dementia due to Alzheimer’s disease, expanding the product’s indications beyond major depressive disorder. The approval and the company’s commer

---
![Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation, Launch Set for June](/uploads/news-images/axsome-therapeutics-wins-fda-nod-for-auvelity-in-a-20260503080116.png)

---
*Originally reported by thelincolnianonline. [Read more](https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html)*

---

*Source: [https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html](https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html)*